Intensive Case Diabetes Management to Prevent Readmission of Previously Identified High Risk Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diabetes
- Sponsor
- Washington University School of Medicine
- Enrollment
- 1
- Locations
- 1
- Primary Endpoint
- Prevent <31 day readmission
- Status
- Terminated
- Last Updated
- 10 years ago
Overview
Brief Summary
The purpose of this study is to assess whether intensive case management interventions by a diabetes team, led by an endocrinologist and certified diabetes educator, can prevent <31 day readmission in previously identified high risk patients with diabetes.The procedures of the study will focus on managing the patient's diabetes and diabetes education while in the hospital, decreasing the patient's risk for hypoglycemia and hyperglycemia in the hospital, and assist in the patient's diabetes management plan for a safe discharge.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients admitted with a diagnosis of diabetes, Patients with a previous history of Pharmacy Expert System (PES) alert, Enrollment in research must be within 24 hours of admission
Exclusion Criteria
- •Patients transferred from institutionalized care, Patients who already plan to move to institutionalized care, Patients with severe co-morbidities (e.g. terminal cancer), Patients admitted for surgery within 24 hours, Patients who are unwilling or unable to give written consent (e.g. dementia), Patients who are homeless, Patients previously admitted to the diabetes endocrine service
Outcomes
Primary Outcomes
Prevent <31 day readmission
Time Frame: The length of time between hospital discharge and readmission 31 days
Primary outcome measure is to assess whether an intensive case management intervention by a diabetes team, led by an endocrinologist and a certified diabetes educator (CDE) , can prevent a \<31 day readmission in previously identified high risk patients with diabetes compared to standard/usual care.
Secondary Outcomes
- improve overall glycemic management(Upon the participant's consent (within 24 hours of hospital admission) to hospital discharge- the average length of stay is five days)